# Mauna Kea Technologies and Tasly Pharmaceutical incorporate joint venture in China

Mauna Kea Technologies and Tasly Pharmaceutical Group have incorporated a joint venture, Tasly Mauna Kea Medical Engineering Technology Co. Ltd., based in Zhejiang province, China. The JV will commercialize Cellvizio in China and develop a neurosurgical platform worldwide.

- Type: Partnership
- Announced: 2022-11-07
- Where: Zhejiang province, China
- Value: $35.0M (35.0M EUR)
- Status: completed
- Products: Cellvizio imaging platform, neurosurgical applications
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Mauna Kea Technologies](https://endata.com/companies/64061.md) (partner)
- [Tasly Pharmaceutical Group](https://endata.com/companies/66478.md) (partner)

## Sources

- [maunakeatech.com](https://www.maunakeatech.com/news/mauna-kea-technologies-and-tasly-pharmaceutical-announce-the-incorporation-of-joint-venture-in-china/), 2022-11-07: "Tasly Mauna Kea Medical Engineering Technology Co. Ltd., based in the Zheijang province of China, is now legally incorporated with registered capital of RMB 250 million."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.